Highland Private Wealth Management Affimed N.V. Transaction History

Highland Private Wealth Management

  • $0
  • Q4 2022

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Oct 17, 2018
SELL
$1.45 - $6.15 $15,950 - $67,650
-11,000 Closed
0 $0
Q2 2018

Aug 07, 2018
BUY
$1.65 - $2.5 $18,150 - $27,500
11,000 New
11,000 $18,000

Others Institutions Holding AFMD

# of Institutions
3
Shares Held
1.09M
Call Options Held
0
Put Options Held
0
View Full List

About Affimed N.V.

AFMD Quotes by TradingView
  • Ticker AFMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,339,008
  • Market Cap $188M
  • Description
  • Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...
More about AFMD
Track This Portfolio

Track Highland Private Wealth Management Portfolio

Follow Highland Private Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Private Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Highland Private Wealth Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email